General Information of Drug (ID:
DR5928) |
Drug Name |
Omidenepag isopropyl
|
Synonyms |
Omidenepag isopropyl|1187451-19-9|DE-117|eybelis|Omidenepag isopropyl [USAN]|G0G0H52U6K|Omidenepag isopropyl (JAN)|Propan-2-yl N-(6-((N-((4-(1H-pyrazol-1-yl)phenyl)methyl)pyridine-3-sulfonamido)methyl)pyridin-2-yl)glycinate|OMIDENEPAG ISOPROPYL [JAN]|Glycine, N-(6-((((4-(1H-pyrazol-1-yl)phenyl)methyl)(3-pyridinylsulfonyl)amino)methyl)-2-pyridinyl)-, 1-methylethyl ester|Glycine, N-[6-[[[[4-(1H-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]-, 1-methylethyl ester|Propan-2-yl N-{6-[(N-{[4-(1H-pyrazol-1-yl)phenyl]methyl}pyridine-3-sulfonamido)methyl]pyridin-2-yl}glycinate|Eybelis (TN)|UNII-G0G0H52U6K|CHEMBL4297666|SCHEMBL15414827|TQR1222|DTXSID001106409|BCP26206|EX-A4371|BDBM50506549|OMIDENEPAG ISOPROPYL [WHO-DD]|AKOS040742334|AT36244|DB15071|SB18739|MS-29656|HY-111406|CS-0040499|OMDI;DE-117; DE 117; DE117|D10966|Q27896252|isopropyl 2-((6-((N-(4-(1H-pyrazol-1-yl)benzyl)pyridine-3-sulfonamido)methyl)pyridin-2-yl)amino)acetate|N-[6-[[[[4-(1H-Pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]glycine 1-methylethyl ester|propan-2-yl 2-[[6-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]pyridin-2-yl]amino]acetate
|
Pharmaceutical Properties |
Molecular Weight |
520.6 |
Topological Polar Surface Area |
128 |
Heavy Atom Count |
37 |
Rotatable Bond Count |
12 |
Hydrogen Bond Donor Count |
1 |
Hydrogen Bond Acceptor Count |
9 |
Cross-matching ID |
- PubChem CID
- 44230999
- Formula
- C26H28N6O4S
- Canonical SMILES
- CC(C)OC(=O)CNC1=CC=CC(=N1)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4
- InChI
- InChI=1S/C26H28N6O4S/c1-20(2)36-26(33)17-28-25-8-3-6-22(30-25)19-31(37(34,35)24-7-4-13-27-16-24)18-21-9-11-23(12-10-21)32-15-5-14-29-32/h3-16,20H,17-19H2,1-2H3,(H,28,30)
- InChIKey
- VIQCWEGEHRBLAC-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.